Prospective Data Analysis of a Quality Improvement Initiative in High Risk

Status Completed

Clinical Trial Summary

This project is designed to assess the impact of implementing a hemodynamic optimization protocol, utilizing flow guided parameters that is provided by technology from Edwards Lifesciences, for patients undergoing high risk cardiac surgery. Importantly, this project is being targeted as a QI initiative because there is no evaluation of new technology or procedures. All technologies and procedures are currently being used for patients undergoing cardiac surgery. Rather this project is evaluating the implementation of a multi-dispclinary developed protocol that seeks to remove variability in which providers are currently treating patients hemodynamics during and acutely after cardiac surgery. Previous research has demonstrated that implementation of hemodynamic management protocols improves perioperative outcome in surgical patients. This project seeks to evaluate the impact of implementing this protocol as the new clinical standard for high-risk cardiac surgery patients. Specifically, this protocol would be a comprehensive hemodynamic management strategy that would-be initiated in the operating room post-bypass and then continued for the first 12 hours in the intensive care unit (see figure below). To restate, all technologies and procedures are currently being performed for these patients, however, there has not been a protocol guiding how practionioners use this technology. The project is evaluating the impact of protocolized treatment strategies. Importantly this protocol has been designed, reviewed and agreed by the motivation of the physicians who are currently responsible for managing these patients hemodynamics. Since this project does involve alterations in procedures or technologies we are seeking to proceed as a quality improvement project. Additionally the protocol is one that has been reviewed and agreed to provide the optimal management strategy for these patients. This again is the overall focus of this project, to implement a hemodynamic management protocol to improve outcomes in patients undergoing cardiac surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Coronary Artery Bypass Graft

Clinical Trial Details

NCT number	NCT04458701
Study type	Observational [Patient Registry]
Source	Loma Linda University
Contact
Status	Completed
Phase
Start date	January 17, 2019
Completion date	June 30, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01688648` - Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft	N/A
Completed	`NCT01596738` - Tranexamic Acid in On-pump CABG With Premature Clopidogrel Cessation	N/A
Completed	`NCT00965471` - Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease	N/A
Completed	`NCT05058222` - Effect of Deep Breathing Exercises on Post Operative Sleep Duration	N/A
Completed	`NCT03299101` - Pilot Testing a Home-Based Rehabilitation Intervention Designed to Improve Outcomes of Frail Veterans Following Cardiothoracic Surgery	N/A
Completed	`NCT01535222` - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery	Phase 2
Completed	`NCT00863044` - High Frequency Ventilation During Off Pump Coronary Artery Bypass Graft (CABG)	Phase 4
Completed	`NCT01932008` - Evaluation of the Bone Mineral Density and Muscle Mass in Patients Post Coronary Artery Bypass Graft Surgery With Chronic Kidney Disease	N/A
Completed	`NCT05349773` - The Pneumatic Tourniquet Technique for Endoscopic Radial Artery Harvest; Does it Affect Patient Hemodynamics?
Completed	`NCT03424382` - CREATION Health Readmission Risk Assessment Tool
Not yet recruiting	`NCT05706545` - Micro- and Macro-Circulation in Cardiac Surgery Patients
Completed	`NCT01572454` - Comparison of Dexmedetomidine and Remifentanil Infusion During CABG	N/A
Completed	`NCT04993976` - Prehabilitation and Coronary Artery Bypass Grafting	N/A
Recruiting	`NCT01629030` - Risk Factors of Sternal Wound Infection After Coronary Artery Bypass Graft	N/A
Completed	`NCT04310995` - Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts	Phase 4
Completed	`NCT03925493` - Exercise Prescription in Cardiac Rehabilitation	N/A
Not yet recruiting	`NCT04485143` - Cloud-based ECG Monitoring and Healthcare Model Building on the Population With Coronary Artery Revascularization
Recruiting	`NCT04231461` - Quality of Life After Cardiac Surgery
Completed	`NCT03002129` - FLuid Responsiveness Prediction Using EXtra Systoles	N/A
Completed	`NCT01591642` - Physical Activity, Functional Fitness and Quality of Life After Coronary Artery Bypass Grafting	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Prospective Data Analysis of a Quality Improvement Initiative in High Risk Cardiac Surgery Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms